Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:49:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied and an older funding notice was removed; these are maintenance updates that do not change trial details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:34:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and a new revision label (v3.4.1); these changes do not alter study details, results, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:39:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary display option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision tag 'Revision: v3.4.0', replacing the previous QC and data labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive content or functionality changes are observed.
    Difference
    0.1%
    Check dated 2026-01-14T02:45:24.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section including Missouri and updated the page revision from v3.3.2 to v3.3.3; the Missouri Locations heading was removed along with the HHS Vulnerability Disclosure item.
    Difference
    0.2%
    Check dated 2025-12-23T17:15:27.000Z thumbnail image

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.